The Safety and Efficacy of Commercial BCMA-Directed CAR T-Cell Therapy in Systemic AL Amyloidosis With Concurrent Myeloma.

Characteristics and Clinical Significance of Myocardial Work in Cardiac Light-Chain Amyloidosis: Pressure-Volume Loop Analysis Based on Cardiac Magnetic Resonance.

Long-Term Outcomes in Patients with Renal Systemic Light Chain Amyloidosis.

Daratumumab plus bortezomib and dexamethasone (Dara-VD) in newly diagnosed Mayo 2004 stage IIIA and IIIB light-chain amyloidosis: Long-term follow-up results from a prospective phase 2 study.

Monoclonal Gammopathies of Thrombotic and Hemorrhagic Significance: Mapping into a classification schema.

Teclistamab Treatment Followed by Heart Transplantation for Advanced Immunoglobulin Light Chain Amyloid Cardiomyopathy.

A Case of Amyloid Light-Chain Amyloidosis Presenting as Colitis.

Zanubrutinib in AL Amyloidosis Associated With Waldenström Macroglobulinemia and Other B-Cell Non-Hodgkin Lymphoma.

Talquetamab induces deep responses in heavily pre-treated patients with systemic light-chain amyloidosis.

Blood phosphorylated tau elevation as a biomarker in immunoglobulin light chain and transthyretin amyloidosis.

Early treatment switch in cardiac AL amyloidosis: a case of suboptimal response to first-line Dara-CyBorD regimen followed by switch to teclistamab.

Long-term outcomes of autologous stem cell transplantation for AL amyloidosis: a 15-year experience from a Chinese referral center and a comparison of different eras.

Right Diaphragmatic Paralysis as Initial Manifestation of AL Amyloidosis.

Clinical impact of lilac-colored aggregates on may-Grünwald-Giemsa-stained bone marrow smears in patients with amyloid light-chain amyloidosis.

Non-invasive differentiation of light chain amyloidosis and multiple myeloma based on Raman spectroscopy analysis using one-dimensional convolutional neural networks.

Predicting Early Mortality in Newly Diagnosed AL Amyloidosis: Development and Validation of the PACE Score for Daratumumab-Treated Patients.

A Case of AL Amyloidosis-Associated Arthritis Initially Misdiagnosed as Rheumatoid Arthritis.

Prognostic Factors and Progression Biomarkers in AL Amyloidosis: Mapping Current Knowledge and Critical Gaps.

Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Heart Failure and Transthyretin or Light Chain Amyloidosis: A Real-World Analysis.

Comparative evaluation of free light chain assays in AL amyloidosis: Performance of Sebia versus Freelite and N-Latex.

Current Standards and Perspectives in Proteomics for Cardiac Amyloidosis.

Case Report: Targeted interleukin-6 blockade by siltuximab for cytokine release syndrome control and infection limitation in thirteen patients treated with bi-specific T-cell engagers.

Negative [99mTc]Tc -DPD Scintigraphy, Presence of Monoclonal Protein and Biopsy Suggestive of AL Amyloidosis in a Patient With Homozygous p.Ala101Val Transthyretin Gene Variant.

AL Amyloidosis Patients Continue to Benefit from HDCT/ASCT Consolidation in the Daratumumab Era.

Association Between Common Variable Immunodeficiency and Pulmonary Amyloidosis: Review.

The Evolving Landscape of Anti-Clonal Therapy in Newly Diagnosed Systemic Light-Chain (AL) Amyloidosis: Evidence- and Time-Based Comparison with Multiple Myeloma.

Concurrence of renal amyloidosis and membranous nephropathy: a case series and literature review.

Validity of Amyloidosis in the Danish National Patient Registry.

A retrospective real-world study assessing diagnostic pattern of light-chain amyloidosis in Japan based on data from the medical data vision claims database.

Utilization and Prognosis of Cardiac Device Implantation in AL Versus ATTR Amyloidosis.

Monoclonal gammopathies of cutaneous significance: A nomenclature and pathophysiology-based classification.

Cryo-EM structures of light chain fibrils from abdominal fat biopsies of multiple myeloma patients.

Invasive pressure-volume loop and PET-MR phenotyping in transthyretin cardiac amyloidosis: a multimodal imaging case report.

Case Report: Contrast adenosine stress echocardiography revealing microvascular dysfunction in cardiac AL amyloidosis.

An Australian Amyloidosis Network analysis of Australian patients with immunoglobulin light chain amyloidosis treated with bortezomib-based chemotherapy.

Immunoglobulin Light Chain Amyloidosis: 2026 Update on Diagnosis, Prognosis, and Treatment.

Hematologic response and kidney outcomes of monoclonal gammopathy of renal significance excluding AL amyloidosis: a report of six cases.

A Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis.

Hepatic-Predominant Immunoglobulin G Lambda Light Chain Amyloidosis Associated With Multiple Myeloma: A Report of an Exceptionally Rare Case.

Clinical practice pattern of management of plasma cell dyscrasia for kidney transplant candidates and recipients in the United States.

Eligibility criteria for clinical trials in AL amyloidosis result in exclusion of nearly half of real-world patients.

Case Report: Image-enhanced endoscopic characteristics of gastric amyloidosis with narrow-band imaging comparison.

Clinical characteristics and prognosis of immunoglobulin light chain amyloidosis patients.

Outcomes of patients with systemic light chain amyloidosis treated with DVD front-line therapy.

Extracellular Vesicles in Cardiac Amyloidosis: From Pathogenesis to Clinical Applications.

Monoclonal gammopathy of renal significance in western China: A large cohort study dominated by amyloidosis with distinct clinical outcomes.

Prognostic Impact of Bone Marrow Plasma Cell Percentage in Patients With Systemic Light-Chain Amyloidosis: A Systematic Review and Meta-Analysis.

The impact of cardiac amyloidosis on patients with multiple myeloma: a systematic review and meta-analysis.

Bridging the Gap in AL and ATTR Cardiac Amyloidosis: Integrating Histopathology, Biomarkers, and Multimodal Imaging for Subtype-Specific Diagnosis.

Diagnostic Journeys and Delays in AL Amyloidosis: Insights From a Cross-Sectional Patient Survey.

Pleural amyloidosis: timely unmasking of apple-green birefringence in pleural biopsy.

[Light chain amyloidosis: multidisciplinary management and innovative therapeutic strategies. SIC/ANMCO Consensus document of the Italian Cardiac Amyloidosis Network (RIAC)].

Bridging Diagnostic Gaps in AL Cardiac Amyloidosis: The Emerging Role of 68Ga-FAPI PET/CT.

Myopathies Associated With Monoclonal Gammopathies of Clinical Significance: A Narrative Review.

Raccoon eyes and macroglossia in AL amyloidosis.

Impact of Kidney Histology and Choice of Treatment on Survival in Patients with Multiple Myeloma.

Primary (AL) Amyloidosis Following COVID-19 Infection: A Case Report.

Challenging features of left ventricular wall thickening in a young patient with multiple myeloma and shock: when magnetic resonance imaging makes the difference-a case report.

Clinical Features of Systemic Amyloidosis: A Scoping Review.

Right Ventricular-Pulmonary Artery Coupling as a Prognostic Marker in Cardiac Amyloidosis: A Comprehensive Review.

American Society of Hematology (ASH) 2026 Guidelines on Diagnosis of Light Chain Amyloidosis.

Past, Present, and Future of Dexamethasone in Multiple Myeloma and AL Amyloidosis.

Clarifying the immunoglobulin light chain variable gene usage in Chinese patients with renal AL amyloidosis.

Systemic light chain cardiac amyloidosis with atrioventricular block.

Surgical Treatment of Primary Localized Cutaneous Nodular Amyloidosis of the Nose: Resection and Reconstruction With a Nasolabial Flap.

Frequency-adjusted daratumumab-based regimen versus bortezomib/dexamethasone in newly diagnosed AL amyloidosis: a matched-cohort study.

Impact of disease-modifying therapies on imaging parameters in cardiac amyloidosis: A systematic review and meta-analysis.

Nodular pulmonary amyloidosis presenting as a localized manifestation of lymphoproliferative disease: A three-case series.

Small molecule stabilization of diverse amyloidogenic immunoglobulin light chains revealed by hydrogen-deuterium exchange mass spectrometry.

Dermatological Manifestations of Amyloid Light-Chain (AL) Amyloidosis: A Case Report Highlighting Early Diagnosis and Treatment.

Hepatic response criteria in light chain amyloidosis: a multicenter validation study.

Early Diagnosis of ATTR-CM Using Carpal Tunnel Biopsy Examination: EDUCATE: A United Kingdom Prospective Multicenter Study.

Hepatic Response Dynamics in Newly Diagnosed Patients with Light-chain Amyloidosis: A Retrospective Cohort Study.

Preclinical and preliminary clinical evaluation of [18F]Florbetazine for non-invasive PET detection of cardiac amyloidosis.

Multimodality Imaging in Cardiac Amyloidosis.

Biopsy-resolved cryo-EM structures of amyloid fibrils provide molecular insights into AL amyloidosis.

Silent progression: cardiac amyloidosis unmasking IgG lambda myeloma in an elderly patient.

Prognostic significance of cardiac biomarkers in patients with AL amyloidosis treated with a daratumumab-based regimen.

The role of cardiac imaging for diagnosis of cardiac amyloidosis: a systematic review and meta-analysis of test accuracy.

Selective Cardiac Tc-99m DPD Retention With Markedly Reduced Extracardiac Uptake in Hereditary Transthyretin Amyloidosis.

Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab era.

Proving Bone Marrow Plasma Cell Clonality by Flow Cytometry: An Important Tool in the Diagnosis of Immunoglobulin Light-Chain Amyloidosis.

Detection yield of surrogate tissue biopsies across amyloidosis classes: a large-scale analysis of 4,027 patients.

Recurrence of light chain crystalline podocytopathy and tubulopathy after kidney transplantation achieving remission with an antimyeloma regimen.

Bortezomib combined with autologous stem cell transplantation overcomes cytogenetic abnormalities in AL amyloidosis.

ALyzer3D.AI: a more generalizable deep learning predictor of light chain amyloidogenicity powered by structural and evolutionary Artificial Intelligence.

2025 Update of Cellular Immunotherapy for Plasma Cell Disorders.

Clinical significance of t(11;14) translocation in systemic AL amyloidosis in the era of daratumumab therapy.

Untwisted amyloid fibrils from a transgenic mouse model of AL amyloidosis.

[ATTR Amyloidosis for Hand Surgeons: A Hidden, Treatable Systemic Disease].

Coronary microvascular dysfunction as an initial clue to the diagnosis of light-chain amyloidosis: a case report.

Cryo-EM structure of renal AL amyloid fibrils from a patient with λ1 light chain amyloidosis.

Avoiding serious treatment-emergent adverse events in Waldenström macroglobulinemia patients.

Cryo-EM of Cardiac AL-224L Amyloid Reveals Shared Structural Motifs and Mutation-induced Differences in λ6 Light Chain Fibrils.

Linvoseltamab in Patients With Relapsed/Refractory Multiple Myeloma in the LINKER-MM1 Study: Longer Follow-Up and Subgroup Analyses.

[Abdominal pain: It still can be a zebra].

A Case of AL Amyloidosis With Hepatomegaly as the Main Clinical Manifestation.

Scintigraphy-Positive Light-Chain Cardiac Amyloidosis.

Up-to-date review on heart transplantation and other advanced heart failure therapies in cardiac amyloidosis patients.

New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System.

Monoclonal-related neuropathies: diagnosis, prognosis, and outcomes.

Endless possibilities and how to exploit them? What is the optimal treatment sequence?

Geometry over thickness: Refining echocardiographic recognition of amyloid cardiomyopathy.

Frontline Dara-CyBorD for AL amyloidosis: high response rates and cytogenetic insights from a real-world cohort.

Pulmonary Amyloidosis as a Differential Diagnosis in Interstitial Lung Diseases.

Real-World Data of Light Chain (AL) Amyloidosis: Prognostic Indices and Treatment Patterns.

A Triad of Telltale Clues: Macroglossia Raccoon Eye and Nerve Compression Unveil Amyloid Light Chain Amyloidosis.

Rethinking response assessment in AL amyloidosis: the role of kidney function and absolute light chain levels.

Polymorphic IGLV6-57 AL amyloid fibrils and features of a shared folding pathway.

The impact of growth factor utilization on infection risk in patients receiving bispecific monoclonal antibodies.

Single-slide detection and typing of AL renal amyloidosis: combining mass spectrometry imaging and digital pathology.

Optimized methods for efficient application of immunogold electron microscopy to amyloid fibrils typing.

Isatuximab: surface strike, deep response in AL amyloidosis.

Isatuximab for relapsed AL amyloidosis.

Amyloid Deposits in a Bone Marrow Biopsy Alongside a Presumed Causative Clone.

Development of an artificial intelligence-based early diagnostic system for light-chain amyloidosis.

The Real-World Safety and Efficacy of Bispecific T-Cell Engager Therapy in Systemic AL Amyloidosis.

The Association of Kidney Function on Survival in Patients with AL Amyloidosis after Autologous Stem Cell Transplantation: A Multicenter Study.

Cardiac Amyloidosis in the Real World: Clinical Presentations, Disease Overlap, and Therapeutic Imperatives.

Efficacy of venetoclax in the treatment of relapsed/refractory light-chain amyloidosis.

Equivocal vs Positive Technetium-99m-Pyrophosphate Scintigraphy for Transthyretin Amyloid Cardiomyopathy: Comparing Outcomes, Demographics, and Imaging.

Twin Diseases in Different Organs: A Cautionary Tale of Anchoring on a Positive Scan.

Impact of early minimal residual disease assessment on the outcomes of patients with systemic light chain amyloidosis.

Novel noninvasive parameters for diagnosis of liver involvement in patients with systemic AL amyloidosis.

Cold pressor test and paradoxical blood pressure reduction in light chain amyloidosis.

Decoding the human tongue of light chain amyloidosis in three dimensions (3D): three-dimensional pathological visualization drives early and precise screening of suspected cases.

Wild-Type Transthyretin Amyloid Cardiomyopathy With Bone Marrow Involvement: Clinical Implications of Less Common Sites of Amyloid Deposition.

Cutaneous light chain amyloidosis and erythema elevatum diutinum as the presenting features of IgA monoclonal gammopathy: a rare case report and comprehensive literature review.

Amyloid and Light Chain Deposition Disorders.

[A rare cause of hoarseness-a case study and compact overview of laryngeal amyloidosis].

BCMA: BeCoMing a new hope for AL amyloidosis.

First case report of talquetamab use in AL amyloidosis.

Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis.

AL amyloidosis: a real-world experience with CAR T-cell therapy.

Profound dFLC decrease after one cycle predicts superior outcome in patients with AL amyloidosis.

Primary Amyloidosis Unmasked by Gastric Biopsy: A Case Report.

Assessment of Treatment Response: Expanding the Applications of 18F-Florbetapir PET Imaging in Light-Chain Cardiac Amyloidosis Beyond Diagnosis and Outcome Prediction.

Performance of Large Language Models in Diagnosing Rare Hematologic Diseases and the Impact of Their Diagnostic Outputs on Physicians: Combined Retrospective and Prospective Study.

Urinary Stricture due to Localized Urethral AL Amyloidosis: A Case Report and Literature Review.

Dimer Dissociation and Aggregation Hot-spot Exposure Synergistically Accelerate Light Chain Variable Domain Aggregation Associated With AL Amyloidosis.

Monoclonal Gammopathy of Clinical Significance-Associated Glycogen Storage Myopathy: A Novel Acquired Muscle Disease.

Multisystem Light Chain Amyloidosis: Diagnostic and Therapeutic Challenges.

Cardiac AL amyloidosis in a veteran endurance athlete with pre-existing apical hypertrophic cardiomyopathy: a case report.

Diagnostic Dilemmas in Cardiac Transthyretin Amyloidosis With Coexistent Low-Grade B-Cell Lymphoma: A Case Report.

Evaluation of Cytokine Levels in Cardiac Transthyretin and Immunoglobulin Light Chain Amyloidosis and Their Correlation with Myocardial Inflammatory Cells and MACE.

Diet-related poor nutritional status as a major challenge in the treatment of patients with amyloidosis: A systematic review.

Bleeding Patterns and Clinical Outcomes in Patients With Systemic AL Amyloidosis-Related Acquired Factor X Deficiency.

Myocardial deformation imaging to monitor treatment response in AL amyloidosis: is it worth the strain?

Improvement in global longitudinal strain following plasma cell-directed therapy is associated with long-term survival among patients with AL amyloidosis.

Molecular Expression Differences in Specific Blood Mononuclear Cell-Types Identify Patients With AL Amyloidosis.

Unmasking amyloid light-chain amyloidosis through biochemical lens: diagnostic utility of urine immunofixation in serum-negative cases.

Dangerous clones with complex ties to AL amyloidosis.

Simultaneous onset of systemic sclerosis and light chain amyloidosis: the first report of a case report and review of the literature.

Echocardiographic AMYLI score in systemic light-chain amyloidosis: Clinical relevance and risk stratification.

Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis.

Changes in Myocardial Light Chain Amyloid Burden After Plasma Cell Therapy.

Isatuximab for relapsed and/or refractory AL amyloidosis: results of a prospective phase 2 trial (SWOG S1702).

Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy-Associated Myopathies.

A tale of two tracers - amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05).

Concurrent TTR and AL Amyloidosis: Diagnostic Challenges and Clinical Implications.

Cardiac light chain amyloidosis secondary to Waldenström's macroglobulinemia: A case report and review.

Comparable peri-transplant mortality and incidence of febrile neutropenia after high-dose melphalan and autologous stem cell transplantation in patients with plasma cell dyscrasias treated as outpatient versus inpatient.

Case report of isolated aortic valve AL-amyloidosis following aortic valve replacement.

Predicting prognosis of light-chain cardiac amyloidosis by magnetic resonance imaging and deep learning.

The Conformational Landscape of AlphaFold2-Predicted Amyloidogenic Light Chains and Their Correlation With VL Domain Mutations and Aggregation Propensity.

In vitro and in vivo disease models of cardiac amyloidosis: progress, pitfalls, and potential.

[Clinical characteristics analysis of patients with IgD type systemic light chain amyloidosis].

Rapidly progressive fatal hepatic failure due to IgM-related AL amyloidosis in Waldenström's macroglobulinemia: an autopsy case report.

BCMA CAR-T: From Multiple Myeloma to Light-Chain Amyloidosis.

Clone-specific residue changes at multiple positions are associated with amyloid formation by antibody light chains.

Advances in imaging-based diagnosis, prognosis, and response assessment in cardiac amyloidosis: a comprehensive multimodality review.

Wild-type transthyretin cardiac amyloidosis: a case of multisystemic involvement and review of literature.

A rare presentation of extramedullary multiple myeloma as a large gluteal soft tissue mass: A case report.

Beyond the Usual Suspects: Clinical and Pathological Insights From a Rare Case of Light Chain (AL) Amyloidosis in a Filipino Patient.

Unexplained cardiac hypertrophy as a clue to plasma cell tumour: a case study.

Localized Nodular Amyloidosis of the Buccal Mucosa Associated with Sjögren's Syndrome: A Case Report and Literature Review.

Concurrent Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patient Treated With Daratumumab and Tafamidis: A Case Report.

Therapeutic role of venous leg compression in worsening heart failure with predominant extravascular congestion: a case report.

Ultrasonographic Features of Amyloid Arthropathy in Light Chain Amyloidosis: A Case Report.

Prognostic value of right ventricular longitudinal strain assessed by multimodal imaging in amyloidosis: systematic review and meta-analysis.

Impact of autonomic dysfunction in light chain amyloidosis patient with nephrotic syndrome and cardiac involvement.

Charting the future of AL amyloidosis: Diagnostic advancements, prognostic insights, and therapeutic challenges.

Spectrum of renal diseases caused by monoclonal immunoglobulin: experience from an Australian tertiary referral centre over a 10-year period.

Wild-type Cardiac Amyloidosis due to Transthyretin Protein - A Review.

Management recommendations for kidney transplantation in patients with plasma cell dyscrasia.

Escherichia coli Cellulitis in a Patient With Waldenström Macroglobulinaemia: A Case Report.

Bispecific T-cell engagers for relapsed/refractory multiple myeloma after solid organ transplantation: A case series.

How to perform and interpret cardiac amyloidosis radionuclide imaging (CARI).

Safety and efficacy of elranatamab in patients with relapsed and/or refractory immunoglobulin light-chain amyloidosis.

Modeling immunoglobulin light chain amyloidosis in Caenorhabditis elegans.

Usefulness of STREI: A new index of right heart function in patients with immunoglobulin light chain cardiac amyloidosis.

Rapid identification of daratumumab interference with M-protein detection using MALDI-TOF mass spectrometry: a case study involving renal light chain amyloidosis.

Current risk stratification and staging of multiple myeloma and related clonal plasma cell disorders.

Accurate MS-Based Diagnostic Amyloid Typing Using Endogenously Normalized Protein Intensities in Formalin-Fixed Paraffin-Embedded Tissue.

Long-term outcomes of light chain amyloidosis patients receiving heart transplant: A single-center experience.

Long-term follow-up of patients with AL amyloidosis treated on a phase 1 trial of CAEL-101.

Atypical Presentation of Systemic Amyloid Light Chain (AL) Amyloidosis.

Recent developments in systemic light-chain amyloidosis prognosis and treatment.